naphazoline has been researched along with Day Blindness in 2 studies
Naphazoline: An adrenergic vasoconstrictor agent used as a decongestant.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ocular toxoplasmosis is a self-limiting disease in immunocompetent individuals; however, proper diagnosis and early intervention improves visual outcome." | 1.35 | A presentation of longstanding toxoplasmosis chorioretinitis. ( Hall, BR; Oliver, GE; Wilkinson, M, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hall, BR | 1 |
| Oliver, GE | 1 |
| Wilkinson, M | 1 |
| Herman, DC | 1 |
| Bartley, GB | 1 |
2 other studies available for naphazoline and Day Blindness
| Article | Year |
|---|---|
A presentation of longstanding toxoplasmosis chorioretinitis.
Topics: Animals; Benzalkonium Compounds; Child; Chorioretinitis; Female; Humans; Naphazoline; Pheniramine; T | 2009 |
Corneal opacities secondary to topical naphazoline and antazoline (Albalon-A).
Topics: Adult; Antazoline; Corneal Opacity; Drug Combinations; Humans; Imidazoles; Male; Naphazoline; Ophtha | 1987 |